Latest Earnings Analysis

• TKO (TKO) Q2 2025: WWE Revenue Jumps 22% as Multi-Platform Rights Strategy Drives Margin Expansion
  August 07, 2025 · TKO
• Universal Technical Institute (UTI) Q3 2025: Concord Growth Unlocked, $204M Revenue Surges on Regulatory Tailwind
  August 07, 2025 · UTI
• Takeda (TAK) Q3 2025: Growth & Launch Products Surge 14.6%, Buyback Signals Capital Flexibility
  August 07, 2025 · TAK
• Solid Power (SLDP) Q2 2025: BMW i7 Test Vehicle Validates Solid-State Progress, 75MT Electrolyte Expansion Targets Commercial Ramp
  August 07, 2025 · SLDP
• Schrödinger (SDGR) Q2 2025: Software Revenue Climbs 15% as Predictive Toxicology Investment Reshapes Margin Profile
  August 07, 2025 · SDGR
• Soleno Therapeutics (SLNO) Q2 2025: 646 Patient Starts Signal Launch Outperformance and Expanding Payer Access
  August 07, 2025 · SLNO
• Jackson Financial (JXN) Q2 2025: RILA Balances Jump 80%, Diversification Drives Capital Return Upside
  August 07, 2025 · JXN
• Exact Sciences (EXAS) Q2 2025: Screening Revenue Climbs 18% as Cologuard Plus and Freenome Deal Reshape Portfolio
  August 07, 2025 · EXAS
• Clearwater Analytics (CWAN) Q2 2025: Gross Margin Surges to 77.4% as Integrated Platform Drives Synergy
  August 07, 2025 · CWAN
• SAHRN (CRNC) Q3 2025: Variable License Revenue Jumps 48% as AI Platform Drives OEM Adoption
  August 07, 2025 · CRNC
• Dutch Bros (BROS) Q2 2025: Shop Count Surges 16% as Transaction Initiatives Accelerate Brand Expansion
  August 07, 2025 · BROS
• Certara (CERT) Q2 2025: SIMSIP EMA Milestone and 50% QSP Biologics Mix Signal Expanding Biosimulation Demand
  August 07, 2025 · CERT
• TARS Q2 2025: Xdemvi Prescriber Base Expands 33%, Unlocking New Eye Care Market Depth
  August 06, 2025 · TARS
• ADMA Biologics (ADMA) Q2 2025: Yield Enhancement Delivers 20% IG Output Gain, Margin Expansion in Focus
  August 06, 2025 · ADMA
• Revolution Medicines (RVMD) Q2 2025: $2B Royalty Pharma Deal Expands Global Oncology Ambition
  August 06, 2025 · RVMD
• Tudor Perini (TPC) Q2 2025: Backlog Doubles to $21.1B, Unlocking Multi-Year Margin Expansion
  August 06, 2025 · TPC
• Gen Restaurant Group (GENK) Q2 2025: Store Count Jumps 50%, Expansion Model Faces Tariff Uncertainty
  August 06, 2025 · GENK
• APEI Q2 2025: $43M Preferred Redemption Reshapes Capital Flexibility for Healthcare and Military Growth
  August 06, 2025 · APEI
• VECO (VECO) Q2 2025: Semiconductor Revenue Surges 13% as AI and Advanced Packaging Drive Demand
  August 06, 2025 · VECO
• Virgin Galactic (SPCE) Q2 2025: Operating Expenses Down 34% as Spaceship Build Phase Advances
  August 06, 2025 · SPCE
• Open Lending (LPRO) Q2 2025: OEM Channel Shrinks to 0.1% as Credit Union Shift Reshapes Profit Mix
  August 06, 2025 · LPRO
• Emergent BioSolutions (EBS) Q2 2025: Net Leverage Drops to 1.9x as MCM and Narcan Rebound
  August 06, 2025 · EBS
• Paycom (PAYC) Q2 2025: IWAN Rollout Drives 450bp Margin Expansion, Signals Next-Gen HCM Shift
  August 06, 2025 · PAYC
• LOD Superfood (LSF) Q2 2025: Wholesale Channel Jumps 47%, Shifting Category Mix and Margin Playbook
  August 06, 2025 · LSF
• DISCO (LAW) Q2 2025: Multi-Terabyte Matters Up 150%, Driving Software Expansion Momentum
  August 06, 2025 · LAW
• Lyft (LYFT) Q2 2025: FreeNow Adds 25% Partnership Penetration, Expanding Global Platform Leverage
  August 06, 2025 · LYFT
• Upwork (UPWK) Q2 2025: AI-Driven GSV Up $80M, Enterprise Acquisitions Set Stage for 2026
  August 06, 2025 · UPWK
• MediaAlpha (MAX) Q2 2025: P&C Transaction Value Jumps 71% as FTC Settlement Resets Health Baseline
  August 06, 2025 · MAX
• Energy Recovery (ERII) Q2 2025: $105M Buyback Authorization Underscores Confidence in Desalination Pipeline
  August 06, 2025 · ERII
• Viper Energy (VNOM) Q2 2025: 15% Per Share Oil Growth Target Anchors Post-Merger Upside
  August 06, 2025 · ET
• TriplePoint Venture Growth (TPVG) Q2 2025: Unfunded Commitments Surge 58% as AI Pipeline Drives Portfolio Expansion
  August 06, 2025 · TPVG
• NextNav (NN) Q2 2025: FCC License Win Unlocks 128 New Markets, Accelerating 5G PNT Push
  August 06, 2025 · NN
• HubSpot (HUBS) Q2 2025: Core Seats Up 25% as Platform Monetization Accelerates
  August 06, 2025 · HUBS
• Magnite (MGNI) Q2 2025: CTV Contribution Rises 14% as Antitrust Tailwinds Build
  August 06, 2025 · MGNI
• Fastly (FSLY) Q2 2025: Security Revenue Jumps 15% as RPO Hits Record $315M
  August 06, 2025 · FSLY
• MaxSight (MXCT) Q2 2025: Core Revenue Guidance Cut by $5M as Customer Consolidations Hit Outlook
  August 06, 2025 · MXCT
• IonQ (IONQ) Q2 2025: R&D Spend Jumps 23% as Quantum Networking Ambitions Scale
  August 06, 2025 · IONQ
• Sensonics (SENS) Q2 2025: New Patient Starts Jump 79% as Eversense 365 Drives Channel Shift
  August 06, 2025 · SENS
• Coru Medical Systems (KRMD) Q2 2025: International Revenue Jumps 34% on Prefilled Syringe Expansion
  August 06, 2025 · KRMD
• Warrior Met Coal (HCC) Q2 2025: Blue Creek Volumes Up 239K Tons, Accelerating Revenue Transition Amid Pricing Pressure
  August 06, 2025 · HCC
• Masterbrand (MBC) Q2 2025: $90M Synergy Target Reshapes Cabinet Industry with American Woodmark Merger
  August 06, 2025 · MBC
• ZVIA Q2 2025: Gross Margin Jumps 680bps as Innovation and Distribution Expand
  August 06, 2025 · ZVIA
• Numora Therapeutics (NMRA) Q2 2025: Cash Runway Extends Into 2027 as Six Clinical Catalysts Approach
  August 06, 2025 · NMRA
• OmniAb (OABI) Q2 2025: Exploration Launch Drives 22% Growth in Post-Discovery Pipeline
  August 06, 2025 · OABI
• Xperi (XPER) Q2 2025: TiVo One Users Surge 3.7M as Revenue Mix Shifts Under Macro Strain
  August 06, 2025 · XPER
• Vasta (VSTA) Q2 2025: Free Cash Flow Jumps 147% as Core and Complementary Solutions Expand
  August 06, 2025 · VSTA
• Vir Biotechnology (VIR) Q2 2025: Operating Expenses Down $42M as Pipeline Advances Across Three Registration Trials
  August 06, 2025 · VIR
• Symbotic (SYM) Q3 2025: Next-Gen Storage Boosts Density by 40%, Resets Deployment Trajectory
  August 06, 2025 · SYM
• Veracyte (VCYT) Q2 2025: Decipher Volume Surges 28%, Anchoring Multi-Year Growth Trajectory
  August 06, 2025 · VCYT
• Tandem Diabetes Care (TNDM) Q2 2025: Pharmacy Channel Expands to 30% Coverage, Margin Path to 60% Affirmed
  August 06, 2025 · TNDM